Phytochemical Name : 23,24-Dihydrocucurbitacin B

Properties Information
PhytoCAT-ID PhytoCAT-1198
Phytochemical name or plant extracts 23,24-Dihydrocucurbitacin B
PMID 17681423
Literature evidence In this study, DHCB, isolated from roots of Trichosanthes kirilowli which is a traditional Chinese herb medicine used as treatments for cancer and other diseases, has been found to inhibit the proliferation of human cancer cell lines Bcap37, HeLa, SW620, SMMC-7721, K562 and MCF-7 in a dose- and time-dependent manner, and induce apoptosis in human breast cancer cell line Bcap37 at low concentration.
IUPAC name [(6R)-6-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxoheptan-2-yl] acetate
Phytochemicals’ class or type of plant extracts Alpha-hydroxy ketone
Source of phytochemicals or plant Extracts Trichosanthes kirilowli
Geographical availability Cambodia, China North-Central, China Southeast, Inner Mongolia, Japan, Korea, Laos, Nansei-shoto, Vietnam
Plant parts Root
Other cancers Breast cancer
Target gene or protein NA
Gene or Protein evidence NA
Target pathways NA
IC50 NA
Potency Flow cytometric analysis revealed that at the lower dose of 1.8 and 3.6muM, DHCB-induced cancer cell lines death via an apoptotic process rather than necrotic one, whereas, the higher dose of 8.9, 17.9 and 35.7muM induced cell death via the necrotic process.
Cell line/ mice model Bcap37, HeLa, SW620, SMMC-7721, K562, MCF-7
Additional information  Cell-cycle analysis demonstrated DHCB induction of G(2)/M phase cell-cycle arrest and apoptosis. The overall results suggest that DHCB might have the therapeutic value against human cancer cell lines, especially the breast cancer cell lines.
PubChem ID 267250
Additional PMIDs NA
Additional sources of information https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:294222-1
Safety NA